STEVEN GILLIS
CIK 1229592 · Ex. Chair. & President · last filed 2026-07-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$150.35M
Companies
10
Total Filings
60
Lifetime Open-Market Net
$134.54M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BOLD | 10%+ Owner | 828,570 | $2.85 | $2.37M | -$199.2K | 1 | 2026-07-06 |
| TAK | Director | 10,400 | $17.49 | $181.9K | $0 | 1 | 2026-07-06 |
| SPTX | 10%+ Owner | 6,294,951 | $23.48 | $147.81M | $138.60M | 1 | 2026-05-04 |
| Metsera, Inc. (MTSR) Delisted | Director | 0 | $70.50 | $0 | $0 | 1 | 2025-11-14 |
| VBI Vaccines Inc/BC (VBIV) Delisted | Director | 1,046,106 | $0.07 | $68.3K | $1.92M | 15 | 2023-07-28 |
| Q32 Bio Inc. (FIXX) Delisted | Director | 37,461 | $16.82 | $630.3K | $0 | 7 | 2023-06-15 |
| Codiak BioSciences, Inc. (CDAK) Delisted | Director | 7,512,653 | $0.06 | $428.2K | $3.52M | 7 | 2023-02-21 |
| PULM | Director | — | $1.58 | — | $0 | 8 | 2020-09-01 |
| bluebird bio, Inc. (BLUE) Delisted | Director | 5,466 | $4.97 | $27.2K | -$9.31M | 10 | 2015-07-30 |
| Trubion Pharmaceuticals, Inc (TRBN) Delisted | Ex. Chair. & President | 0 | — | — | $0 | 6 | 2010-10-28 |
Recent Filings · Page 4 of 6
60 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-06 | PULM | Grant (A) | — | $0 | EDGAR |
| 2018-04-04 | Q32 Bio Inc. (FIXX) Delisted | Conv (C) | +6,068,695 | $0 | EDGAR |
| 2018-03-29 | Q32 Bio Inc. (FIXX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-25 | VBI Vaccines Inc/BC (VBIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-10-31 | VBI Vaccines Inc/BC (VBIV) Delisted | Buy (P) | +300,000 | $915.0K | EDGAR |
| 2017-06-16 | VBI Vaccines Inc/BC (VBIV) Delisted | Exer (M) | +18,750 | $0 | EDGAR |
| 2017-05-30 | — | Grant (A) | — | $0 | |
| 2017-03-31 | VBI Vaccines Inc/BC (VBIV) Delisted | Mixed | +6,377 | $15.9K | EDGAR |
| 2017-03-22 | PULM | Grant (A) | — | $0 | EDGAR |
| 2016-06-02 | — | Grant (A) | — | $0 |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.